Shubhrajit Barman

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Anwesha Kar, Puspendu Ghosh, Anupam Gautam, Snehanshu Chowdhury, Debashree Basak, Ishita Sarkar, Arpita Bhoumik, Shubhrajit Barman, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Senthil Kumar Ganesan, Sandip Paul, Shilpak Chatterjee
CD38-RyR2 axis-mediated signaling impedes CD8 + T cell response to anti-PD1 therapy in cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Anwesha Kar, Puspendu Ghosh, Anupam Gautam, Snehanshu Chowdhury, Debashree Basak, Ishita Sarkar, Arpita Bhoumik, Shubhrajit Barman, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Senthil Kumar Ganesan, Sandip Paul, Shilpak Chatterjee
CD38-RyR2 axis-mediated signaling impedes CD8 + T cell response to anti-PD1 therapy in cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Anwesha Kar, Puspendu Ghosh, Anupam Gautam, Snehanshu Chowdhury, Debashree Basak, Ishita Sarkar, Arpita Bhoumik, Shubhrajit Barman, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Senthil Kumar Ganesan, Sandip Paul, Shilpak Chatterjee
CD38-RyR2 axis-mediated signaling impedes CD8 + T cell response to anti-PD1 therapy in cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Anwesha Kar, Puspendu Ghosh, Anupam Gautam, Snehanshu Chowdhury, Debashree Basak, Ishita Sarkar, Arpita Bhoumik, Shubhrajit Barman, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Senthil Kumar Ganesan, Sandip Paul, Shilpak Chatterjee
CD38-RyR2 axis-mediated signaling impedes CD8 + T cell response to anti-PD1 therapy in cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)
Anwesha Kar, Puspendu Ghosh, Anupam Gautam, Snehanshu Chowdhury, Debashree Basak, Ishita Sarkar, Arpita Bhoumik, Shubhrajit Barman, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Senthil Kumar Ganesan, Sandip Paul, Shilpak Chatterjee
CD38-RyR2 axis-mediated signaling impedes CD8 + T cell response to anti-PD1 therapy in cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (11) (2024)